BackEntia Biosciences Overview

Entia Biosciences Total Current Liabilities

Entia Biosciences's total current liabilities is $2.1M.

Get informed when a big investor buys or sells

+ Follow
Total Current Liabilities
$2.11M
↑ 69.84% YoYΔ $865830.00 vs prior year quarter

Peer trimmed avg / median

Loading

Entia Biosciences Total Current Liabilities History

Loading

Entia Biosciences vs. peers: Total Current Liabilities Comparison

Loading

Entia Biosciences Total Current Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Entia Biosciences (ERGO) FAQ

As of the most recent data (December 2016), ERGO shows a total current liabilities of $2.1M. That compares with $1.2M in the prior-year period — up 69.8% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, ERGO's total current liabilities is now $2.1M (was $1.2M) — a 69.8% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Entia Biosciences is outperforming or lagging.

Tracking ERGO's total current liabilities over time shows whether Entia Biosciences is scaling, shrinking, or reshaping that part of the business. The current reading is $2.1M That compares with $1.2M in the prior-year period — up 69.8% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this total current liabilities page, Stockcircle has Entia Biosciences's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total current liabilities (currently $2.1M) with ownership activity and broader fundamentals.